Dave Brinckerhoff is the owner of MSI Automation Inc. out of Wichita, Kansas. He comes from a family of engineers and innovators. Through the use of his expertise and his manufacturing company, Dave is making strides in system development against cancer. MSI Automation is featuring a new direction in nanotechnology that will help treat cancer, defined as magnetic nanoparticle hyperthermia (MHT).
“The objective of this technology is to develop a means to treat cancer, especially in Third World countries where air and water pollution and food contamination is a serious and growing problem,” said Dave Brinkerhoff. “Unfortunately, the success of nanoparticle hyperthermia is limited by the apparatus to magnetically heat the nanoparticles.”
According to Dave, in addition to his treatment for bone cancer at Beijing University earlier this year, prostate cancer research at Northwestern University and 41 other MSI Automation systems worldwide have proven the technology successful but only on small lab animals.
“From my own observations, I have concluded that the magnetic hyperthermia instrument needed to be re-engineered,” said Brinckerhoff. “Conventional magnetic heating devices were too limited in power and thus could not be scaled up to heat nanoparticles inside realistic-sized body parts like arms, legs, breasts, throat, etc.”
The new design discards traditional round heating coils, which lose significant magnetic heating power when enlarged. Utilizing MSI Automation’s new technology, magnetic hyperthermia instruments will have twice the magnetic power and the heating power can be focused into a narrow beam from different directions at a tumor.
“The new system is on a completely different track and provides substantial improvements in magnetic heating power and ease of use,” said Brinckerhoff.
According to MSI Automation, its magnetic compression arrangement design is superior to traditional round heating coils used for nanoparticle heating. The new system will allow large animal treatment and the possibility of some human cancer treatments.
Most of MSI Automation’s business is currently done overseas due to the emphasis in nanotechnology in Asia, India and the Middle East. Because of the aperture size of the heating system, the target treatment markets are skin and bone cancer. Magnetic hyperthermia can also complement chemotherapy, as chemo is toxic to even healthy tissue.
“Down the road I want to also offer a miniaturized heating device such that a surgeon can use it for internal hyperthermia treatments of liver and pancreatic cancers. These cancers currently lack any viable treatment method,” said Brinckerhoff.
MSI Automation originated in the New York City area, however, 15 years ago Dave moved his business to Wichita, Kansas. “There were several reasons to choose to move my business to Wichita. But foremost was the local infrastructure featuring a concentrated array of suppliers and machine shops in a single location,” said Brinkerhoff. “This was important because my company is a manufacturer and I need easy access to suppliers of metals, industrial parts and sophisticated machining facilities.”
Through personal experience, innovative thinking and a convenient location to do business, Dave Brinkerhoff and MSI Automation are using new technology that hopes to treat some types of deadly cancer.